FI104168B1 - Menetelmä terapeuttisesti käyttökelpoisten retinoidiyhdisteiden valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten retinoidiyhdisteiden valmistamiseksi

Info

Publication number
FI104168B1
FI104168B1 FI914405A FI914405A FI104168B1 FI 104168 B1 FI104168 B1 FI 104168B1 FI 914405 A FI914405 A FI 914405A FI 914405 A FI914405 A FI 914405A FI 104168 B1 FI104168 B1 FI 104168B1
Authority
FI
Finland
Prior art keywords
preparation
therapeutically useful
retinoid compounds
useful retinoid
compounds
Prior art date
Application number
FI914405A
Other languages
English (en)
Swedish (sv)
Other versions
FI914405A0 (fi
FI914405L (fi
FI104168B (fi
Inventor
F Ivy Carroll
Anita Lewin
Kenneth Tramposch
Stephen A Steiner
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of FI914405A0 publication Critical patent/FI914405A0/fi
Publication of FI914405L publication Critical patent/FI914405L/fi
Application granted granted Critical
Publication of FI104168B1 publication Critical patent/FI104168B1/fi
Publication of FI104168B publication Critical patent/FI104168B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/64—Monocyclic acids with unsaturation outside the aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/20—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by carboxyl groups or halides, anhydrides, or (thio)esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09—Geometrical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
FI914405A 1990-09-21 1991-09-19 Menetelmä terapeuttisesti käyttökelpoisten retinoidiyhdisteiden valmistamiseksi FI104168B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/586,159 US5141959A (en) 1990-09-21 1990-09-21 Isoprenoid phospholipase a2 inhibitors and preparations comprising same
US58615990 1990-09-21

Publications (4)

Publication Number Publication Date
FI914405A0 FI914405A0 (fi) 1991-09-19
FI914405L FI914405L (fi) 1992-03-22
FI104168B1 true FI104168B1 (fi) 1999-11-30
FI104168B FI104168B (fi) 1999-11-30

Family

ID=24344545

Family Applications (1)

Application Number Title Priority Date Filing Date
FI914405A FI104168B (fi) 1990-09-21 1991-09-19 Menetelmä terapeuttisesti käyttökelpoisten retinoidiyhdisteiden valmistamiseksi

Country Status (18)

Country Link
US (1) US5141959A (fi)
EP (1) EP0476682B1 (fi)
JP (1) JP2943089B2 (fi)
AT (1) ATE117979T1 (fi)
AU (1) AU637756B2 (fi)
CA (1) CA2051766A1 (fi)
DE (1) DE69107153T2 (fi)
DK (1) DK0476682T3 (fi)
ES (1) ES2067822T3 (fi)
FI (1) FI104168B (fi)
GR (1) GR3014944T3 (fi)
IE (1) IE66745B1 (fi)
IL (1) IL99536A (fi)
MX (1) MX9101163A (fi)
NZ (1) NZ239844A (fi)
OA (1) OA09514A (fi)
PT (1) PT99014B (fi)
ZA (1) ZA917531B (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7189737B2 (en) * 1991-08-09 2007-03-13 Research Triangle Institute Cocaine receptor binding ligands
US5436369A (en) * 1993-06-16 1995-07-25 Bristol-Myers Squibb Company Alicyclic phospholipase A2 inhibitors
US5688781A (en) * 1994-08-19 1997-11-18 Bristol-Myers Squibb Company Method for treating vascular leak syndrome
FR2735371B1 (fr) * 1995-06-19 1997-07-18 Cird Galderma Procede pour identifier des composes antagonistes des recepteurs rars
US6900228B1 (en) 1998-03-10 2005-05-31 Research Triangle Institute Opiate compounds, methods of making and methods of use
US6267945B1 (en) * 1998-12-18 2001-07-31 Neuromed Technologies, Inc. Farnesol-related calcium channel blockers
US6538010B1 (en) * 2000-11-08 2003-03-25 Research Triangle Institute Compounds and methods for promoting smoking cessation
US6495719B2 (en) * 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US7842727B2 (en) * 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
WO2003099272A1 (en) * 2002-05-22 2003-12-04 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
AU2003237397A1 (en) * 2002-06-04 2003-12-19 Sequenom, Inc. Diagnosing predisposition to fat deposition and therapeutic methods for reducing fat deposition and treatment of associated conditions
WO2004002295A2 (en) * 2002-06-27 2004-01-08 Sequenom, Inc. Diagnosing predisposition to fat deposition and associated condition
US20050014158A1 (en) * 2002-06-27 2005-01-20 Adam Gail Isabel Reid Therapeutic methods for reducing fat deposition and treating associated conditions
WO2004046104A2 (en) * 2002-11-20 2004-06-03 Errant Gene Therapeutics, Llc Treatment of lung cells with histone deacetylase inhibitors
CA2587013A1 (en) * 2004-11-08 2006-05-18 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7872023B2 (en) * 2005-02-17 2011-01-18 Research Triangle Institute Kappa opioid receptor ligands
US7399762B2 (en) * 2005-04-25 2008-07-15 Research Triangle Institute Opioid receptor agonist compounds and their use in treatment of pain
US7476679B2 (en) * 2005-07-26 2009-01-13 Research Triangle Institute Octahydroisoquinoline compounds as opioid receptor modulators
BRPI0810063A2 (pt) * 2007-04-20 2014-10-14 Acucela Inc Composto, composição farmacêutica, e, métodos para modular fluxo de cromóforo em um ciclo retinóide, para tratar uma doença ou distúrbio oftálmico em um indivíduo, para inibir adaptação ao escuro em uma célula fotorreceptora de bastão da retina, para inibir regeneração de rodopsina em uma célula fotoreceptora de bastão da retina, para reduzir isquemia em um olho de um indivíduo, para inibir neovascularização na retina de um olho de um indivíduo, e para inibir degeneração de uma célula da retina em uma retina
US8048895B2 (en) * 2008-04-18 2011-11-01 Research Triangle Institute Kappa opioid receptor ligands
CA2787037C (en) 2010-02-24 2018-04-10 Research Triangle Institute Arylpiperazine opioid receptor antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4194007A (en) * 1978-01-13 1980-03-18 Scott Eugene J Van α-Hydroxyretinoic acid, α-ketoretinoic acid and mixtures and their use in treating skin conditions
US4456618A (en) * 1982-10-15 1984-06-26 Sri International Naphthenic and heterocyclic retinoic acid analogues
US4568757A (en) * 1984-01-30 1986-02-04 Research Triangle Institute Configurationally locked retinoids

Also Published As

Publication number Publication date
ATE117979T1 (de) 1995-02-15
JP2943089B2 (ja) 1999-08-30
US5141959A (en) 1992-08-25
ZA917531B (en) 1992-07-29
PT99014A (pt) 1992-08-31
CA2051766A1 (en) 1992-03-22
OA09514A (en) 1992-11-15
ES2067822T3 (es) 1995-04-01
PT99014B (pt) 1999-02-26
IE913318A1 (en) 1992-02-25
AU8462691A (en) 1992-03-26
FI914405A0 (fi) 1991-09-19
EP0476682A1 (en) 1992-03-25
DK0476682T3 (da) 1995-04-03
IL99536A0 (en) 1992-08-18
FI914405L (fi) 1992-03-22
NZ239844A (en) 1993-04-28
DE69107153T2 (de) 1995-05-24
IL99536A (en) 1995-10-31
AU637756B2 (en) 1993-06-03
FI104168B (fi) 1999-11-30
EP0476682B1 (en) 1995-02-01
GR3014944T3 (en) 1995-05-31
DE69107153D1 (de) 1995-03-16
IE66745B1 (en) 1996-02-07
MX9101163A (es) 1992-05-04
JPH04270261A (ja) 1992-09-25

Similar Documents

Publication Publication Date Title
FI104168B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten retinoidiyhdisteiden valmistamiseksi
NO180718C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive mercaptoacetylamidderivater
FR2378521A1 (fr) Derives du carbostyrile, utiles notamment comme stimulants des centres b- adrenorecepteurs, et leur procede de preparation
FR2421874A1 (fr) Carboxyalkylacylamino-acides utiles comme agents hypotenseurs
FI892497A0 (fi) Menetelmä terapeuttisesti aktiivisten bentsamidijohdannaisten valmistamiseksi
SE8302694D0 (sv) Immunomodulating agent
FI935944A0 (fi) Pyratsolopyrimidin- samt pyrimidinylbisfosfonestrar som anti- inflammatorer
FR2400018A1 (fr) Nouveaux acides imidazolinylbenzoiques, leurs esters et leurs sels, leur procede de preparation et leur application comme insecticides
KR910021363A (ko) 락트산 아실화물, 그의 염, 그의 제조 방법 및 이들을 함유하는 조성물
FR2394522A1 (fr) Nouveaux derives d'acides (s-phenenyl tris(carbonylimino))-5,5',5''tri-benzene-carboxyliques utiles notamment comme inhibiteurs du complement, et leur procede de preparation
SE8600046L (sv) Anvendning av en esterforening som temporer baktericid och produkt innehallande esterforeningen
BR9103665A (pt) Composicao inseticida e processo para a producao de um composto
FR2422638A1 (fr) Nouveaux derives de 3,3-dichloro-2-azetidinone, utiles notamment comme agents anti-inflammatoires
FR2430232A1 (fr) Nouveaux acides arylaminobenzoiques utiles notamment comme agents hypoglycemiants
IT1140998B (it) Sali di endo-8-metil-8-sin-alchil-8-azoniabiciclo aperta par. quadrata 3.2.1. chiusa par. quadrata-ottan-3-alchilcarbossilati, processo per la loro preparazione e composizioni terapeutiche che li contengono come principio attivo
ES8303372A1 (es) Procedimiento para la fabricacion de un compuesto de fenil-5-alquiltiazolidina-4-ona, 2-substituida
EP0802179A4 (en) DERIVATE SUBSTITUTED AMIDINONAPHTHYLESTER
FI103885B1 (fi) Menetelmä terapeuttisesti aktiivisten 1-bentsyyli-4-fenyylipiperatsiinijohdannaisten valmistamiseksi ja välituotteina käyttökelpoisia yhdisteitä
FR2429211A1 (fr) Procede de production de derives de n-methylbenzothiazolone substitues en position 4
DK309579A (da) Fremgangsmaade til fremstilling af alfaethynylaminosyrer og estere deraf
PT94243A (pt) Processo para preparacao de inibidores beta-lactamicos de elastase
FR2395262A1 (fr) Nouveaux acides quinoleiniques utiles notamment comme antiinflammatoires et leur procede de preparation
SE7900889L (sv) Sett att framstella xantonderivat
DK534383D0 (da) Fremgangsmade til fremstilling af acetylsalicylsyrederivater
FR2418793A1 (fr) Nouveaux acides hexahydro-1-mercaptoacyl-1h-azepine-2-carboxyliques et leurs esters, utiles notamment comme inhibiteurs de l'hypertension reliee a l'angiotensine